Cargando…

Emerging targets in cancer drug resistance

Drug resistance is a complex phenomenon that frequently develops as a failure to chemotherapy during cancer treatment. Malignant cells increasingly generate resistance to various chemotherapeutic drugs through distinct mechanisms and pathways. Understanding the molecular mechanisms involved in drug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Shashank, Kushwaha, Prem Prakash, Gupta, Sanjay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	OAE Publishing Inc. 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992633/ https://www.ncbi.nlm.nih.gov/pubmed/35582722 http://dx.doi.org/10.20517/cdr.2018.27

Ejemplares similares

Role of prostate cancer stem-like cells in the development of antiandrogen resistance
por: Kushwaha, Prem Prakash, et al.
Publicado: (2022)

Emerging Role of Migration and Invasion Enhancer 1 (MIEN1) in Cancer Progression and Metastasis
por: Kushwaha, Prem Prakash, et al.
Publicado: (2019)

New insights for drug resistance in metastatic castration-resistant prostate cancer
por: Kushwaha, Prem Prakash, et al.
Publicado: (2022)

Resistance to second generation antiandrogens in prostate cancer: pathways and mechanisms
por: Verma, Shiv, et al.
Publicado: (2020)

Aquaporins as Prognostic Biomarker in Prostate Cancer
por: Kushwaha, Prem Prakash, et al.
Publicado: (2023)

Identification of FDA approved drugs and nucleoside analogues as potential SARS-CoV-2 A1pp domain inhibitor: An in silico study
por: Singh, Atul Kumar, et al.
Publicado: (2021)

Phytochemicals present in Indian ginseng possess potential to inhibit SARS-CoV-2 virulence: A molecular docking and MD simulation study
por: Kushwaha, Prem Prakash, et al.
Publicado: (2021)

Contributions of human ACE2 and TMPRSS2 in determining host–pathogen interaction of COVID-19
por: SENAPATI, SABYASACHI, et al.
Publicado: (2021)

Targeting Breast Cancer-Derived Stem Cells by Dietary Phytochemicals: A Strategy for Cancer Prevention and Treatment
por: Prajapati, Kumari Sunita, et al.
Publicado: (2022)

Drug target therapy and emerging clinical relevance of exosomes in meningeal tumors
por: Sharma, Swati, et al.
Publicado: (2023)

Identification of Natural Inhibitors Against SARS-CoV-2 Drugable Targets Using Molecular Docking, Molecular Dynamics Simulation, and MM-PBSA Approach
por: Kushwaha, Prem Prakash, et al.
Publicado: (2021)

Withania somnifera phytochemicals possess SARS-CoV-2 RdRp and human TMPRSS2 protein binding potential
por: Prajapati, Kumari Sunita, et al.
Publicado: (2022)

Editorial: Targeting triple negative breast cancer by natural compounds
por: Kumar, Shashank, et al.
Publicado: (2023)

Five-Decade Update on Chemopreventive and Other Pharmacological Potential of Kurarinone: a Natural Flavanone
por: Kumar, Shashank, et al.
Publicado: (2021)

Increased cytokine gene expression and cognition risk associated with androgen deprivation therapy
por: Verma, Shiv, et al.
Publicado: (2022)

Neuroprotective and Neurorescue Mode of Action of Bacopa monnieri (L.) Wettst in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson’s Disease: An In Silico and In Vivo Study
por: Singh, Babita, et al.
Publicado: (2021)

Naphthylisoindolinone alkaloids: the first ring-contracted naphthylisoquinolines, from the tropical liana Ancistrocladus abbreviatus, with cytotoxic activity
por: Fayez, Shaimaa, et al.
Publicado: (2022)

Correction: Naphthylisoindolinone alkaloids: the first ring-contracted naphthylisoquinolines, from the tropical liana Ancistrocladus abbreviatus, with cytotoxic activity
por: Fayez, Shaimaa, et al.
Publicado: (2022)

The Multifaceted Role of Signal Peptide-CUB-EGF Domain-Containing Protein (SCUBE) in Cancer
por: Kumar, Shashank, et al.
Publicado: (2022)

Editorial: miRNAs and their role in endocrine cancer progression: from prognosis to treatment
por: Kushwaha, Prem Prakash, et al.
Publicado: (2023)

Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy
por: Lim, Zuan-Fu, et al.
Publicado: (2019)

Exosomes as Emerging Drug Delivery and Diagnostic Modality for Breast Cancer: Recent Advances in Isolation and Application
por: Kumar, Dulla Naveen, et al.
Publicado: (2022)

Carbon Nanotubes: An Emerging Drug Carrier for Targeting Cancer Cells
por: Rastogi, Vaibhav, et al.
Publicado: (2014)

GPR68: An Emerging Drug Target in Cancer
por: Wiley, Shu Z., et al.
Publicado: (2019)

Targeted Therapy and Mechanisms of Drug Resistance in Breast Cancer
por: Kinnel, Briana, et al.
Publicado: (2023)

Dietary phytochemicals and their role in cancer chemoprevention
por: Kumar, Shashank, et al.
Publicado: (2021)

Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies
por: Hattinger, Claudia Maria, et al.
Publicado: (2021)

Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian Cancers
por: McFadden, Melayshia, et al.
Publicado: (2021)

Antifungal metabolites, their novel sources, and targets to combat drug resistance
por: Choudhary, Megha, et al.
Publicado: (2022)

Extracellular Vesicles: Emerging Modulators of Cancer Drug Resistance
por: Fontana, Fabrizio, et al.
Publicado: (2021)

Emerging Roles of SKP2 in Cancer Drug Resistance
por: Wu, Ting, et al.
Publicado: (2021)

Exosomes: Emerging Modulators of Pancreatic Cancer Drug Resistance
por: Di Donato, Marzia, et al.
Publicado: (2023)

Emerging Drug Targets for Endometriosis
por: Dolmans, Marie-Madeleine, et al.
Publicado: (2022)

GNL3 and PA2G4 as Prognostic Biomarkers in Prostate Cancer
por: Kumar, Shashank, et al.
Publicado: (2023)

How do antimalarial drugs reach their intracellular targets?
por: Basore, Katherine, et al.
Publicado: (2015)

Candida auris: An Overview of the Emerging Drug-Resistant Fungal Infection
por: Sanyaolu, Adekunle, et al.
Publicado: (2022)

Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue
por: Gote, Vrinda, et al.
Publicado: (2021)

Emerging Role of miRNAs in the Drug Resistance of Gastric Cancer
por: Riquelme, Ismael, et al.
Publicado: (2016)

Nanodelivery systems: An efficient and target‐specific approach for drug‐resistant cancers
por: Ashique, Sumel, et al.
Publicado: (2023)

Emerging role of glucocorticoid receptor in castration resistant prostate cancer: A potential therapeutic target
por: Kumar, Raj
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_63vjku6j9v1rfii4nhndv508cl